Prolactinomas, An interdisciplinary approach
  1. 449 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF
Book details
Table of contents
Citations

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Prolactinomas, An interdisciplinary approach by Ludwig M. Auer, Georg Leb, Gerhard Tscherne, Wolfgang Urdl, Gerhard F. Walter, Ludwig M. Auer, Georg Leb, Gerhard Tscherne, Wolfgang Urdl, Gerhard F. Walter in PDF and/or ePUB format, as well as other popular books in Medicine & Medical Theory, Practice & Reference. We have over one million books available in our catalogue for you to explore.

Information

Publisher
De Gruyter
Year
2015
ISBN
9783110853858

Table of contents

  1. I Morphology
  2. Structure and ultrastructure of prolactinomas
  3. Prolactinomas and mixed adenomas with prolactin cells: an immunohistochemical study of the subcellular localization of hormones
  4. Immunocytochemical, chemical and nuclear-DNA studies of pituitary tumours
  5. Hyperplasia of prolactin pituitary cells with or without microadenoma
  6. Hormone-secretion in cell culture of microprolactinomas, periadenomatous tissue and capsules
  7. Immunocytochemical ultrastructural and culture characteristics of prolactin-secreting pituitary adenomas
  8. Immunohistochemical hormone determinations in pituitary adenomas in comparison with endocrinological findings in vivo
  9. New immunocytochemical observations in prolactinomas
  10. Problematic divergencies between clinical and immunocytochemical findings in prolactinomas
  11. Necrosis of prolactinoma cells after bromocriptine treatment
  12. Spontaneous pituitary lesions and plasma prolactin levels in rats
  13. II Radiology
  14. CT-findings in pituitary adenomas
  15. Comparative study of normal subjects and cases with microadenoma on high-resolution computed tomography
  16. III Endocrinological and clinical aspects
  17. Actions of dopamine receptor agonists at the pituitary level
  18. Dopamine and prolactinomas
  19. Rhythmometric study of the circadian profile of plasma prolactin in patients with prolactinoma or empty sella syndrome
  20. Prolactin responses to thyrotropin-releasing hormone, metoclopramide and insulin- induced hypoglycaemia in hyperprolactinaemic and normoprolactinaemic patients
  21. Evidence for functional impairment of growth hormone secretion in prolactinoma
  22. THS response to dopamine receptor blockade in women with PRL-secreting microadenoma: long lasting effect of surgical removal
  23. Prolactin and TSH responses to TRH and domperidone in delayed puberty
  24. Anterior pituitary function in patients with prolactinomas
  25. Pituitary adenomas with hyperprolactinaemia in males
  26. Prolactinoma in multiple endocrine neoplasia type I
  27. Recurrence of hyperprolactinaemia detected in long-term follow-up of surgically normalised microprolactinomas
  28. Impairment of pituitary hormone secretion in patients with prolactinoma
  29. IV Surgical treatment
  30. The recurrence of pituitary adenoma — a management challenge
  31. Transsphenoidal operations for prolactinomas
  32. Prolactinomas: surgical results in 96 cases
  33. Effect of transsphenoidal surgery on pituitary function
  34. Transsphenoidal microsurgical treatment of 77 prolactinomas
  35. Review of 56 prolactin-secreting pituitary adenomas
  36. The effect of transsphenoidal selective microadenomectomy on patients with prolactinomas
  37. Surgical results and long-term follow-up in female and male prolactinomas
  38. Otoliquorrhoea in large prolactinomas. Pathomechanism and surgical management
  39. Invasive prolactinomas in adolescents
  40. Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas
  41. Long-term follow-up of prolactinomas. Clinical and morphologic correlation
  42. Clinicopathological and neurosurgical comparative analysis of operated recurrent prolactinomas and non-secreting chromophobe pituitary adenomas
  43. V Pharmacotherapy
  44. New aspects of medical treatment of prolactinomas
  45. Conservative management of prolactinoma
  46. Effect of bromocriptine therapy on large prolactinomas
  47. Macroprolactinomas in male patients: efficiency of treatment with a new dopaminergic drug (CU 32-085-Sandoz), tumor calcification and relative significance of preoperative tumour volume regression as estimated by CT-scan
  48. Evidence for spontaneous tumour shrinkage in a 45-year-old patient with a 20-year history of untreated microprolactinoma
  49. The influence of various forms of treatment on serum levels of prolactin, growth hormone and insulin-like growth factors I and II in patients with hyperprolactinaemia and acromegaly
  50. Persisting partial suppression of growth hormone excess in acromegaly after long-term treatment with bromocriptine
  51. Medical and surgical treatment of micro- and macroprolactinomas: seven years followup of 65 cases
  52. VI Aspects of gynecology and obstetrics
  53. Management of prolactinomas in pregnancy
  54. Long-term follow-up of hyperprolactinaemia in women
  55. Prophylactic bromocriptine treatment during pregnancy of women with macroprolactinomas: report of thirteen pregnancies
  56. Natural regression after pregnancy of a CT visualized microprolactinoma
  57. Prolactin levels and ovarian function after surgical treatment of prolactinomas
  58. Pregnancies after treatment of prolactinomas — course and complications
  59. Psychosomatic findings in patients with elevated prolactin
  60. List of contributors
  61. Authors’ index
  62. Subject index